학술논문
Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation.
Document Type
article
Author
Bopp, Selina; Pasaje, Charisse; Summers, Robert; Magistrado-Coxen, Pamela; Schindler, Kyra; Corpas-Lopez, Victoriano; Yeo, Tomas; Mok, Sachel; Dey, Sumanta; Smick, Sebastian; Nasamu, Armiyaw; Demas, Allison; Milne, Rachel; Wiedemar, Natalie; Corey, Victoria; Gomez-Lorenzo, Maria; Franco, Virginia; Early, Angela; Lukens, Amanda; Milner, Danny; Furtado, Jeremy; Gamo, Francisco-Javier; Winzeler, Elizabeth; Volkman, Sarah; Duffey, Maëlle; Laleu, Benoît; Fidock, David; Wyllie, Susan; Niles, Jacquin; Wirth, Dyann
Source
Nature Communications. 14(1)
Subject
Language
Abstract
Identifying how small molecules act to kill malaria parasites can lead to new chemically validated targets. By pressuring Plasmodium falciparum asexual blood stage parasites with three novel structurally-unrelated antimalarial compounds (MMV665924, MMV019719 and MMV897615), and performing whole-genome sequence analysis on resistant parasite lines, we identify multiple mutations in the P. falciparum acyl-CoA synthetase (ACS) genes PfACS10 (PF3D7_0525100, M300I, A268D/V, F427L) and PfACS11 (PF3D7_1238800, F387V, D648Y, and E668K). Allelic replacement and thermal proteome profiling validates PfACS10 as a target of these compounds. We demonstrate that this protein is essential for parasite growth by conditional knockdown and observe increased compound susceptibility upon reduced expression. Inhibition of PfACS10 leads to a reduction in triacylglycerols and a buildup of its lipid precursors, providing key insights into its function. Analysis of the PfACS11 gene and its mutations point to a role in mediating resistance via decreased protein stability.